Dry Eye & Ocular Surface Diseases Diagnostic Platform, C.DIAG® (Quantel Medical)
Product Name Dry Eye & Ocular Surface Diseases Diagnostic Platform
Model Name C.DIAG®
Brand Name Quantel Medical
Country of Origin France
C.DIAG® – Advanced Diagnostic Platform for Dry Eye & Ocular Surface Diseases
C.DIAG® is a premium, fully automated diagnostic platform dedicated to dry eye disease and ocular surface disorders. Developed by Quantel Medical, C.DIAG integrates multiple objective examinations into a single workflow, enabling accurate, reproducible, and comprehensive evaluation of the ocular surface.
Featuring high-definition imaging, transillumination meibography, and intelligent software assistance, C.DIAG supports clinicians in diagnosing, quantifying, and monitoring dry eye disease. As part of Quantel Medical’s C.SUITE™ ecosystem, C.DIAG forms the diagnostic cornerstone for modern, data-driven dry eye management.
Product Description – Overview
| Feature | Description |
| Technology Type | Automated ocular surface diagnostic platform |
| Primary Applications | Dry eye disease and ocular surface disorders |
| Key Examinations | Meibography, tear film analysis, blink assessment |
| Imaging Technology | HD imaging with transillumination meibography |
| Clinical Workflow | Automated, objective and reproducible assessments |
| System Integration | Part of Quantel Medical C.SUITE™ dry eye solution |
- Comprehensive Dry Eye Diagnostics – Designed to support accurate ocular surface evaluation.
- Automated & Objective Analysis – Enhances reproducibility and clinical confidence.
- Advanced Meibography – Enables detailed visualization of Meibomian gland structure.
- Patient-Friendly Workflow – Streamlined exams with intuitive interface.
- Integrated Dry Eye Ecosystem – Works seamlessly with C.STIM® treatment platform.
- Future-Ready Diagnostic Solution – Built for modern dry eye management.